Lanka Ventures PLC’s investment to drive innovations in healthcare technology

The investment firm, Lanka Ventures PLC has announced a strategic investment in Jendo Innovations, a cutting-edge biomedical engineering startup based in Sri Lanka. Jendo Innovations has pioneered a revolutionary medical device designed to advance the early diagnosis of vascular diseases, and this significant investment is poised to propel their innovation into the global healthcare market. Jendo Innovations’ groundbreaking product, the Jendo device, has garnered widespread attention for its ability to analyze endothelial function, a critical indicator in the early stages of numerous cardiovascular diseases. By harnessing the power of non-invasive techniques such as Photoplethysmography (PPG) and Digital Thermal Monitoring (DTM), the Jendo device ensures a comfortable and seamless experience for patients while delivering highly accurate results.

The device’s cloud-based artificial intelligence system further amplifies its capabilities by efficiently processing and analyzing data. This makes it an invaluable tool for diagnosing conditions like atherosclerosis, nephropathy, neuropathy, and varicose veins, transforming the landscape of vascular health assessment. What sets Jendo Innovations apart is its pioneering diagnostics methods for vascular assessment, which has undergone extensive clinical testing and received patents in key markets such as the United States, Japan, and Sri Lanka.